Leica Biosystems Expands FDA-Cleared Digital Pathology
Vista, California, August,11, 2026 Leica Biosystems, a Danaher company and global provider of anatomic and digital pathology solutions, has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Vista, California, August,11, 2026 Leica Biosystems, a Danaher company and global provider of anatomic and digital pathology solutions, has...
SAN DIEGO, Calif., June 3, 2026 Zepto Life Technology has achieved a significant regulatory milestone after receiving U.S. Food...
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...
IRVINE, Calif., May 6, 2026 Helio Genomics announced publication of landmark clinical data demonstrating that its HelioLiverâ„¢ multi-analyte blood...
